Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View
暂无分享,去创建一个
D. Georgescu | D. Lighezan | D. Nistor | Abhinav Sharma | C. Rosca | N. Kundnani | D. Nisulescu | Marioara Nicula Neagu
[1] T. Benfield,et al. Circulating Adiponectin Levels Are Inversely Associated with Mortality and Respiratory Failure in Patients Hospitalized with COVID-19 , 2023, International journal of endocrinology.
[2] Klaus P. Ebmeier,et al. Association of gout with brain reserve and vulnerability to neurodegenerative disease , 2022, medRxiv.
[3] K. Tsilidis,et al. Metabolic syndrome and cognition: A systematic review across cognitive domains and a bibliometric analysis , 2022, Frontiers in Psychology.
[4] A. Ducharme,et al. Atrial Electrical Remodeling in Mice With Cardiac‐Specific Overexpression of Angiotensin II Type 1 Receptor , 2022, Journal of the American Heart Association.
[5] Leonida Gherasim Md PhD PhD,et al. Association of Atrial Fibrillation with Diabetes Mellitus, High Risk Comorbidities. , 2022, Maedica.
[6] M. Bała,et al. The role of glucose in cognition, risk of dementia, and related biomarkers in individuals without type 2 diabetes mellitus or the metabolic syndrome: A systematic review of observational studies , 2022, Neuroscience & Biobehavioral Reviews.
[7] J. Luchsinger,et al. Metabolic Syndrome and Cognitive Function , 2021, Current Cardiology Reports.
[8] Meng Wang,et al. Association between adiponectin‐to‐leptin ratio and heart rate variability in new‐onset paroxysmal atrial fibrillation: A retrospective cohort study , 2021, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.
[9] Chiadi E. Ndumele,et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.
[10] E. Roselló-Lletí,et al. Adipokines and Inflammation: Focus on Cardiovascular Diseases , 2020, International journal of molecular sciences.
[11] G. Mancia,et al. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease. , 2020, European journal of internal medicine.
[12] S. Whitehead,et al. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer’s disease rat model , 2020, Journal of Neuroinflammation.
[13] P. Whelton,et al. High Blood Pressure and Cardiovascular Disease , 2019, Hypertension.
[14] Y. Uspensky,et al. Pathogenetic pathways of cognitive dysfunction and dementia in metabolic syndrome. , 2019, Life sciences.
[15] S. Black,et al. Preventing dementia by preventing stroke: The Berlin Manifesto , 2019, Alzheimer's & Dementia.
[16] Ming-Hsiu Wu. Adiponectin: a pivotal role in the protection against cerebral ischemic injury , 2019, Neuroimmunology and Neuroinflammation.
[17] S. Liatis,et al. Obesity and cardiovascular disease: revisiting an old relationship. , 2019, Metabolism: clinical and experimental.
[18] V. Trischitta,et al. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality , 2017, Diabetes.
[19] A. Pandey,et al. Obesity and Atrial Fibrillation Prevalence, Pathogenesis, and Prognosis: Effects of Weight Loss and Exercise. , 2017, Journal of the American College of Cardiology.
[20] A. Dominiczak,et al. Allopurinol and Cardiovascular Outcomes in Adults With Hypertension , 2016, Hypertension.
[21] S. Sharma,et al. Lowering Uric Acid With Allopurinol Improves Insulin Resistance and Systemic Inflammation in Asymptomatic Hyperuricemia , 2015, Journal of Investigative Medicine.
[22] G. Lip,et al. Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. , 2015, Heart rhythm.
[23] R. Mahajan,et al. The implications of obesity for cardiac arrhythmia mechanisms and management. , 2015, The Canadian journal of cardiology.
[24] Moyses Szklo,et al. Blood Lipids and the Incidence of Atrial Fibrillation: The Multi‐Ethnic Study of Atherosclerosis and the Framingham Heart Study , 2014, Journal of the American Heart Association.
[25] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[26] J. Yue,et al. Cross-sectional study examining the association between metabolic syndrome and cognitive function among the oldest old. , 2013, Journal of the American Medical Directors Association.
[27] Tong Liu,et al. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation. , 2013, Cardiology journal.
[28] M. Böhm,et al. Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition , 2010 .
[29] Paul L. Huang. A comprehensive definition for metabolic syndrome , 2009, Disease Models & Mechanisms.
[30] M. Kivipelto,et al. Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women , 2006, Dementia and Geriatric Cognitive Disorders.
[31] V. Abedi,et al. Obesity and mortality after the first ischemic stroke: Is obesity paradox real? , 2021, PloS one.
[32] S. Suzuki. "Cholesterol paradox" in atrial fibrillation. , 2011, Circulation journal : official journal of the Japanese Circulation Society.